Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control study
Journal of Antimicrobial Chemotherapy · 2024
DOI: 10.1093/jac/dkae157 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2024. Verfasst von Hongyu Zhou und 23 weiteren Autor:innen. Beteiligte Einrichtung: Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland. Hauptthemen laut MEDLINE: Enterobacteriaceae Infections, Bacteremia, Anti-Bacterial Agents, Carbapenems. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia, Innovación y Universidades, Chongqing Health Commission of China, Swiss National Science Foundation.
Abstract (Originalsprache)
Background
Carbapenem-resistant Enterobacterales (CRE) bloodstream infections (BSIs) are a major threat to patients. To date, data on risk factors have been limited, with low internal and external validity. In this multicentre study, risk factors for CRE BSI were determined by comparison with two control groups: patients with carbapenem-susceptible Enterobacterales (CSE) BSI, and patients without Enterobacterales infection (uninfected patients).
Methods
A multicentre, case-control-control study was nested in a European prospective cohort study on CRE (EURECA). CRE BSI:CSE BSI matching was 1:1, CRE BSI:Uninfected patients matching was 1:3, based on hospital, ward and length of stay. Conditional logistic regression was applied.
Results
From March 2016 to November 2018, 73 CRE BSIs, 73 CSE BSIs and 219 uninfected patients were included from 18 European hospitals. For CRE versus CSE BSI, previous CRE colonization/infection [incidence rate ratio (IRR) 7.32; 95% CI 1.65–32.38) increased the risk. For CRE versus uninfected controls, independent risk factors included: older age (IRR 1.03; 95% CI 1.01–1.06), patient referral (long-term care facility: IRR 7.19; 95% CI 1.51–34.24; acute care hospital: IRR 5.26; 95% CI 1.61–17.11), previous colonization/infection with other MDR organisms (MDROs) (IRR 9.71; 95% CI 2.33–40.56), haemodialysis (IRR 8.59; 95% CI 1.82–40.53), invasive procedures (IRR 5.66; 95% CI 2.11–15.16), and β-lactam/β-lactamase inhibitor combinations (IRR 3.92; 95% CI 1.68–9.13) or third/fourth generation cephalosporin (IRR 2.75; 95% CI 1.06–7.11) exposure within 3 months before enrolment.
Conclusions
Evidence of previous CRE colonization/infection was a major risk factor for carbapenem resistance among Enterobacterales BSI. Compared with uninfected patients, evidence of previous MDRO colonization/infection and healthcare exposure were important risk factors for CRE BSI. Targeted screening, infection prevention and antimicrobial stewardship should focus on these high-risk patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
- Department of Hospital Infection Control, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Infection Antimicrobials Modeling Evolution (IAME) U 1137, INSERM, Université Paris-Cité, Paris, France.
- Unidad Clínica de Medicina Interna, Hospital Universitario Virgen Macarena, Seville, Spain.
- Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Departamento de Medicina, Universidad de Sevilla, Seville, Spain.
- Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Seville, Spain.
ORCID-Profile: Niccolò Buetti, Belén Gutiérrez-Gutiérrez, Rafael Canton, Murat Akova, Jesus Rodriguez-Baño, Marlieke E A De Kraker
Förderung
- Ministerio de Ciencia, Innovación y Universidades
- Chongqing Health Commission of China
- Swiss National Science Foundation
Zitieren
APA
Zhou, H., Buetti, N., Pérez-Galera, S., Bravo-Ferrer, J., Gutiérrez-Gutiérrez, B., Paniagua-García, M., Feifel, J., Sauser, J., Kostyanev, T., Canton, R., Tan, L. K., Basoulis, D., Pintado, V., Roilides, E., Dragovac, G., Torre-Cisneros, J., Mediç, D., Akova, M., Goossens, H., …, & COMBACTE- EURECA project team (2024). Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control study. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkae157
Vancouver
Zhou H, Buetti N, Pérez-Galera S, Bravo-Ferrer J, Gutiérrez-Gutiérrez B, Paniagua-García M, et al. Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control study. Journal of Antimicrobial Chemotherapy. 2024. doi:10.1093/jac/dkae157
BibTeX
@article{Zhou2024,
author = {Zhou, Hongyu and Buetti, Niccolò and Pérez-Galera, Salvador and Bravo-Ferrer, Jose and Gutiérrez-Gutiérrez, Belén and Paniagua-García, María and Feifel, Jan and Sauser, Julien and Kostyanev, Tomi and Canton, Rafael and Tan, Lionel K and Basoulis, Dimitris and Pintado, Vicente and Roilides, Emmanuel and Dragovac, Gorana and Torre-Cisneros, Julian and Mediç, Deana and Akova, Murat and Goossens, Herman and Bonten, Marc and Harbarth, Stephan and Rodriguez-Baño, Jesus and De Kraker, Marlieke E A and COMBACTE- EURECA project team, COMBACTE- EURECA project team},
title = {Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control study},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2024},
doi = {10.1093/jac/dkae157}
}
EUVIMED